NCT04610450

Brief Summary

The cochlear implant is a neural prosthesis and has been the gold standard treatment for severe to profound sensorineural hearing loss over several decades. The surgical procedure for cochlear implantation aims to atraumatically insert the electrode array of the cochlear implant into the cochlea. However, due to the location of the cochlea inside the skull, the surgeon is required to create an access from the surface of the temporal bone to the cochlea (inner ear). In conventional methods, this access is acquired by removal of portions of the mastoid bone through a mastoidectomy and posterior tympanotomy. The outcome and success of the conventional procedure varies due to mainly two factors: surgeon skill and subject anatomical variation. To overcome these variables toward a more consistent and less invasive cochlear implantation surgery, the development of robotic and image guided cochlear implantation has taken place. This study primarily aims to explore the performance of robotic cochlear implantation surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 22, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 30, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

April 26, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 23, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 23, 2022

Completed
Last Updated

November 25, 2022

Status Verified

May 1, 2022

Enrollment Period

1.6 years

First QC Date

October 22, 2020

Last Update Submit

November 23, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Relative ratio of successful electrode array insertions through the drilled direct cochlear access with the HEARO procedure to the total HEARO procedures.

    The primary outcome measure of this study is to explore the relative ratio of the successful electrode array insertions into the cochlea through the drilled direct cochlear access with the HEARO procedure to the total HEARO procedures. Aborted or converted procedures count as procedure in which insertion through the direct cochlea access was not possible. The results will be expressed in relative numbers and in percentage.

    day 0

Secondary Outcomes (9)

  • Electrode array insertion outcome

    day 0

  • Electrode array insertion outcome

    day 0

  • Electrode array insertion outcome

    day 0

  • Insertion depth prediction accuracy

    day 0

  • Absolute angular accuracy of the drilled tunnel access

    day 0

  • +4 more secondary outcomes

Study Arms (1)

RCI-BE-10

EXPERIMENTAL

Robot assisted cochlear implant surgery.

Device: HEARODevice: OTOPLAN

Interventions

HEARODEVICE

Robotic system for otological procedures

RCI-BE-10
OTOPLANDEVICE

Otological surgical planning software

RCI-BE-10

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects scheduled for CI surgery according to clinical routine
  • Subjects who will receive a cochlear implant
  • Signed and dated informed consent form

You may not qualify if:

  • Age under 18 years
  • Pregnancy
  • Distance of the planned trajectory to the facial nerve is \< 0.4 mm as per screening CT scan
  • Distance of the planned trajectory to the chorda tympani is \< 0.3 mm as per screening CT scan
  • A safe inner ear access cannot be planned for preservation of RW membrane and cochlear structures
  • Individuals where image guidance or robotic procedures are not indicated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inselspital, Bern University Hospital

Bern, 3010, Switzerland

Location

MeSH Terms

Conditions

Hearing Loss, Sensorineural

Condition Hierarchy (Ancestors)

Hearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Marco Caversaccio, Prof. Dr.

    University Hospital Bern (Inselspital)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 22, 2020

First Posted

October 30, 2020

Study Start

April 26, 2021

Primary Completion

November 23, 2022

Study Completion

November 23, 2022

Last Updated

November 25, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations